SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW.X, also known as crow with knife, is gaining traction as a meme coin with a strong community backing it across multiple chains like $SOL.X, $CRO.X, and $ETH.X. The community emphasizes its fully circulated supply, organic growth, and deflationary mechanisms as key factors for its potential.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as retail traders speculate on potential government contracts following a congressional disclosure of stock purchases, sparking comparisons to $PLTR. The community is actively discussing chart patterns and a potential short squeeze, with bullish investors highlighting the company's AI-driven solutions and anticipating a breakout. Chatter revolves around potential gains amidst growing interest in AI for defense and security.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses Elon Musk's recent $1 billion stock purchase, which many see as a sign of confidence and a potential catalyst for further gains. Community members are debating whether this is a bull trap or a genuine shift in momentum, with some pointing to technical indicators and others highlighting concerns about fundamentals. Overall, the focus is on how Musk's actions will impact the stock's trajectory amidst ongoing discussions about Tesla's future in AI and robotics.

Slopana

Slopana is trending as community members rally around the meme coin, touting its strong community, doxxed leadership, and unique position within the Solana ecosystem. Conversations highlight its availability on Phantom Wallet and potential for significant growth, with some suggesting it could become Solana's mascot. The coin's association with the term 'digital slop' coined by a Solana co-creator is also a key talking point.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire ($RDW) is trending amid a newly announced partnership with Honeywell to develop quantum-secure satellite communication systems. The community is focused on the potential of this collaboration, particularly its implications for the company's future earnings and potential for a short squeeze given high short interest. Some investors are also weighing in on a recent settlement related to accounting irregularities, while others express optimism about the space sector and RDW's long-term prospects.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster ($OUST) is trending due to its strategic partnership with Constellis, a major security firm, to integrate its lidar technology into global security operations, potentially opening a new $100B market. The community is excited about the potential for significant revenue growth and Ouster's role in physical AI. Broader discussions include the company's strong financial position, defense contracts, and expansion into smart city infrastructure, with some analysts predicting a continued upward trend.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community, the Wolfpack, rallies around the project, drawing comparisons to the early days of Shiba Inu and Saitama. Community members express strong conviction, anticipating significant gains and highlighting the project's solid floor and dedicated development team. Talk centers around a potential breakout and the revival of the 'Inu season' within the crypto space.

GME Ethereum

GME Ethereum ($GME.X) is trending amidst community excitement, with some users anticipating a "God Candle" and a tweet from Roaring Kitty. Some users are pointing to a new website and speculation around potential connections to GameStop or the involvement of key figures like FBB4, while others express concern about a delisting from Revolut and question the legitimacy of its ties to Gamestop, calling it a scam.

Moo Deng

Moo Deng is trending due to a recent listing on Upbit, South Korea's largest crypto exchange, sparking a notable price surge. Community members are actively discussing potential price targets and whether this meme coin can sustain its momentum, with some drawing comparisons to other Solana-based tokens. Despite positive sentiment, some traders express concern over the coin's correlation with Bitcoin's price movements and overall volatility.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna's NYSE debut is sparking lively discussions around its valuation, potential for short squeezes, and comparisons to competitors like Affirm and PayPal. Community members are weighing the company's growth prospects, particularly in the US market, against concerns about profitability and the buy-now-pay-later business model. Some are optimistic about its long-term potential, citing its large user base and integration with major retailers, while others express caution, pointing to potential selling pressure and the overall economic climate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer

NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.

NovoCure (NVCR) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for NovoCure (NVCR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of +7.69% and +3.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Soars 5.3%: Is Further Upside Left in the Stock?

NovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

What Makes NovoCure (NVCR) a New Buy Stock

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial

Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect?

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update

Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to...

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference

Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive Officer...

Shares of Novocure Ltd. skyrocketed over 55% on Monday afternoon, reaching levels last seen in August 2023, as the company announced promising Phase 3 trial results for its Tumor Treating Fields (TTFields) therapy.&nbsp;Trading volume surged to more than seven times the daily average, underscoring heightened investor interest.The pivotal PANOVA-3 trial, conducted jointly by Novocure and Zai Lab, evaluated TTFields therapy in combination with gemcitabine and nab-paclitaxel as a first-line treatment for unresectable, locally advanced pancreatic adenocarcinoma.&nbsp;The trial met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS).&nbsp;Patients receiving TTFields alongside the standard chemotherapy regimen achieved an mOS of 16.2 months, compared to 14.2 months for those treated with chemotherapy alone, marking a two-month survival advantage.&nbsp;Additionally, TTFields demonstrated a 33% improvement in the survival rate at 24 months, with the therapy being well-tolerated and exhibiting a consistent safety profile.TTFields therapy, an FDA-approved treatment designed to disrupt cancer cell division using electric fields, is already under investigation for multiple cancer types, including glioblastoma and mesothelioma.&nbsp;Novocure plans to seek regulatory approval for TTFields in pancreatic cancer based on the PANOVA-3 data and aims to present the findings at an upcoming medical congress.&nbsp;Zai Lab intends to file for regulatory approval in China.<figure class="image"><a href="https://stocktwits.com/symbol/NVCR"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NVCR_sentiment_meter_and_message_volume_on_Dec_2_dd14a0b3d0.png" alt="NVCR sentiment meter and message volume on Dec 2.png" width="1314" height="320"></a><figcaption>NVCR sentiment meter and message volume on Dec 2 as of 2:20 pm ET | source: Stocktwits</figcaption></figure>Retail investors reacted enthusiastically on Stocktwits, propelling sentiment for Novocure to ‘extremely bullish’ as message volumes soared.&nbsp;<stembedurl>https://stocktwits.com/vandy84/message/594738690</stembedurl><stembedurl>https://stocktwits.com/Chazdaq/message/594725063</stembedurl>Wall Street analysts also took notice. H.C. Wainwright raised its price target on Novocure to $38 from $30, highlighting the significant market opportunity in pancreatic cancer and projecting global peak sales of $1.7 billion by 2037.&nbsp;Leerink lifted its target to $33 from $28, citing the potential revenue upside from TTFields indications in non-small cell lung cancer and glioblastoma.&nbsp;Ahead of the trial readout on Monday, Evercore ISI upgraded Novocure to ‘Outperform’ from ‘In Line’ and raised the price target to $30 from $18. The brokerage said if it were to assume about 50% probability for success, it would lead to peak revenue of greater than $500 million and about 30% penetration, with about 50% upside to NVCR shares in a base case.Looking ahead, Novocure is continuing its exploration of TTFields in metastatic pancreatic cancer through the ongoing PANOVA-4 Phase 2 trial. The study, which combines TTFields with atezolizumab, gemcitabine, and nab-paclitaxel, has completed enrollment, with data expected in 2026.Novocure’s shares have gained over 115% year-to-date, positioning the company for renewed momentum in the biotech sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-rises-after-upgrade-price-target-hikes/cJ9kq43RhE">Tesla Stock Rises After Massive Price Target Hikes On Trump, AI Factors: Retail’s Charged Up</a>

Novocure plans to seek regulatory approval for TTFields in pancreatic cancer based on the PANOVA-3 data and aims to present the findings at an upcoming medical congress. 

Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges

The trial met its primary endpoint, showing a statistically significant improvement in median overall survival.

Equity

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Current Price	$12.72
Prev Close	$12.15
Open	$12.39
Dividend Yield	0.00%
50-Day Moving Average	$13.30
Beta	1.23
Avg. Volume	1.58M
PE Ratio	-7.78

52-Week High	$34.13
52-Week Low	$10.87
Market Capitalization	$1.36B
EPS (Annual)	-$1.56
Price to Book	3.89
Revenue Per Employee	$406,733.87
Enterprise Value/EBITDA	N/A

NVCR
NovoCure Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVCR News

NVCR NovoCure Ltd